跳至主要内容
临床试验/NCT02727673
NCT02727673已完成不适用

A Prospective Randomized Trial on the Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology

Eastern Hepatobiliary Surgery Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,000
试验地点
1
主要终点
the overall survival rate of each group

研究概览

简要总结

The aim of this study is to establish a platform of detecting and sorting circulating tumor stem cells from peripheral blood in HCC patients; to investigate the relationship between circulating tumor stem cells and their effects on postoperative recurrence and metastasis, in order to provide a new therapeutic target for hepatocellular carcinoma treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients > 18 years and <=70 years of age;
  • No dysfunction in major organs; Blood routine, kidney function, cardiac function and lung function are basically normal.
  • Patients who can understand this trial and have signed information consent

排除标准

  • Reject to attend;
  • Impossible to come to our hospital for physical examination regularly;
  • Patients with other diseases which may affect the treatment mentioned

结局指标

主要结局

the overall survival rate of each group

时间窗: 3 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ShenFeng

vice president of the Eastern Hepatobiliary Surgery Hospital

Eastern Hepatobiliary Surgery Hospital

研究点 (1)

Loading locations...

相似试验